|
|
||||||||
AJP - Cell Physiology, Vol 265, Issue 3 C740-C747, Copyright © 1993 by American Physiological Society
ARTICLES |
L. S. Jacobs and M. Kester
Department of Physiology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
The role of sphingolipids in mediating the action of platelet-derived growth factor (PDGF) has been investigated in the vascular smooth muscle-derived A7r5 cell line. L-Cycloserine (2 mM), an inhibitor of sphingolipid synthesis, caused time-dependent inhibition of [3H]serine incorporation into [3H]sphingomyelin in A7r5 cells. PDGF-AB (10 ng/ml), PDGF-BB (10 ng/ml), or sphingosine (10 microM) independently stimulated [3H]thymidine incorporation into DNA in A7r5 cells. L-Cycloserine (2 mM) inhibited stimulation of DNA synthesis by both PDGF-AB and PDGF-BB. L-Cycloserine (2 mM, 16 h) did not affect the ability of PDGF or sphingosine to increase intracellular free calcium ([Ca2+]i) in A7r5 cells loaded with the fluorescent indicator fura 2. Measurement of adenine nucleotide levels in A7r5 cell extracts by reverse-phase high-performance liquid chromatography indicated that treatment with L-cycloserine did not adversely affect cellular metabolism. To determine directly whether PDGF activates sphingolipid metabolism, A7r5 cells were labeled with [3H]serine for 48 h and then treated with PDGF-AB (10 ng/ml) for 1 h. Sphingolipids were separated by thin-layer chromatography and quantified by liquid scintillation counting. PDGF-AB stimulated an increase in [3H]sphingosine from 25.5 +/- 3.0 to 37.5 +/- 4.1 counts.min-1 (cpm).micrograms protein-1 and a concomitant decrease in [3H]ceramide from 24.3 +/- 3.2 to 18.5 +/- 2.9 cpm/micrograms protein. These data suggest that the PDGF-stimulated increase in [Ca2+]i is not sufficient for induction of DNA synthesis and that mitogenic effects of PDGF in vascular smooth muscle cells are mediated by sphingolipid metabolism.
This article has been cited by other articles:
![]() |
R. Charles, L. Sandirasegarane, J. Yun, N. Bourbon, R. Wilson, R. P. Rothstein, S. W. Levison, and M. Kester Ceramide-Coated Balloon Catheters Limit Neointimal Hyperplasia After Stretch Injury in Carotid Arteries Circ. Res., August 18, 2000; 87(4): 282 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sandirasegarane, R. Charles, N. Bourbon, and M. Kester NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: implications for vascular growth arrest Am J Physiol Cell Physiol, July 1, 2000; 279(1): C225 - C235. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Auge, M. Nikolova-Karakashian, S. Carpentier, S. Parthasarathy, A. Negre-Salvayre, R. Salvayre, A. H. Merrill Jr., and T. Levade Role of Sphingosine 1-Phosphate in the Mitogenesis Induced by Oxidized Low Density Lipoprotein in Smooth Muscle Cells via Activation of Sphingomyelinase, Ceramidase, and Sphingosine Kinase J. Biol. Chem., July 30, 1999; 274(31): 21533 - 21538. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hisano, Y. Yatomi, K. Satoh, S. Akimoto, M. Mitsumata, M. A. Fujino, and Y. Ozaki Induction and Suppression of Endothelial Cell Apoptosis by Sphingolipids: A Possible In Vitro Model for Cell-Cell Interactions Between Platelets and Endothelial Cells Blood, June 15, 1999; 93(12): 4293 - 4299. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. MacDonell, D. L. Severson, and W. R. Giles Depression of excitability by sphingosine 1-phosphate in rat ventricular myocytes Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2291 - H2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-Y. Chin and S.-H. Chueh Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway Am J Physiol Cell Physiol, November 1, 1998; 275(5): C1255 - C1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mathes, A. Fleig, and R. Penner Calcium Release-activated Calcium Current (ICRAC) Is a Direct Target for Sphingosine J. Biol. Chem., September 25, 1998; 273(39): 25020 - 25030. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S.S. Rani, F. Wang, E. Fuior, A. Berger, J. Wu, T. W. Sturgill, D. Beitner-Johnson, D. LeRoith, L. Varticovski, and S. Spiegel Divergence in Signal Transduction Pathways of Platelet-derived Growth Factor (PDGF) and Epidermal Growth Factor (EGF) Receptors. INVOLVEMENT OF SPHINGOSINE 1-PHOSPHATE IN PDGF BUT NOT EGF SIGNALING J. Biol. Chem., April 18, 1997; 272(16): 10777 - 10783. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pietruck, A. Moritz, M. Montemurro, A. Sell, S. Busch, D. Rosskopf, S. Virchow, H. Esche, N. Brockmeyer, K. H. Jakobs, et al. Selectively Enhanced Cellular Signaling by Gi Proteins in Essential Hypertension: G{alpha}i2, G{alpha}i3, Gß1, and Gß2 Are Not Mutated Circ. Res., November 1, 1996; 79(5): 974 - 983. [Abstract] [Full Text] |
||||
![]() |
S. A. Lapidot and R. D. Phair Platelet-Derived Growth Factor Causes Sustained Depletion of Both Inositol Trisphosphate-Sensitive and Caffeine-Sensitive Intracellular Calcium Stores in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 44 - 51. [Abstract] [Full Text] |
||||
![]() |
C. C. King, E. M. M. Gardiner, F. T. Zenke, B. P. Bohl, A. C. Newton, B. A. Hemmings, and G. M. Bokoch p21-activated Kinase (PAK1) Is Phosphorylated and Activated by 3-Phosphoinositide-dependent Kinase-1 (PDK1) J. Biol. Chem., December 22, 2000; 275(52): 41201 - 41209. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |